View More View Less
  • 1 Center for Psychiatric Medicine, North Andover, MA, USA
  • | 2 University of Florida, College of Medicine, Gainesville, FL, USA
  • | 3 Department of Clinical Medicine, Malibu Beach Recovery Center, Malibu Beach, CA, USA
  • | 4 Department of Clinical Neurology, PATH Foundation NY, NY, USA
  • | 5 University of Vermont and Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA
  • | 6 Dominion Diagnostics, LLC, North Kingstown, RI, USA
  • | 7 Institute of Integrative Omics and Applied Biotechnology (IIOAB), Nonakuri, Purbe Medinpur, West Bengal, India
  • | 8 Victory Nutrition, LLC, Austin, TX, USA
  • | 9 RDSolutions, LLC, La Jolla, CA, USA
  • | 10 IGENE, LLC, Austin, TX, USA
  • | 11 Boston University School of Medicine, and Boston VA Healthcare, Boston, MA, USA
  • | 12 Dominion Diagnostics, LLC, North Kingstown, RI, USA
  • | 13 Rivermend Health, LLC, Atlanta, GA, USA
Open access

Background

Lucid dreams are frequently pleasant and training techniques have been developed to teach dreamers to induce them. In addition, the induction of lucid dreams has also been used as a way to ameliorate nightmares. On the other hand, lucid dreams may be associated with psychiatric conditions, including Post-Traumatic Stress Disorder (PTSD) and Reward Deficiency Syndrome-associated diagnoses. In the latter conditions, lucid dreams can assume an unpleasant and frequently terrifying character.

Case presentations

We present two cases of dramatic alleviation of terrifying lucid dreams in patients with PTSD. In the first case study, a 51-year-old, obese woman, diagnosed with PTSD and depression, had attempted suicide and experienced terrifying lucid nightmares linked to sexual/physical abuse from early childhood by family members including her alcoholic father. Her vivid “bad dreams” remained refractory in spite of 6 months of treatment with Dialectical Behavioral Therapy (DBT) and standard pharmaceutical agents which included prazosin, clonidie and Adderall. The second 39-year-old PTSD woman patient had also suffered from lucid nightmares.

Results

The medication visit notes reveal changes in the frequency, intensity and nature of these dreams after the complex putative dopamine agonist KB220Z was added to the first patient’s regimen. The patient reported her first experience of an extended period of happy dreams. The second PTSD patient, who had suffered from lucid nightmares, was administered KB220Z to attenuate methadone withdrawal symptoms and incidentally reported dreams full of happiness and laughter.

Conclusions

These cases are discussed with reference to the known effects of KB220Z including enhanced dopamine homeostasis and functional connectivity of brain reward circuitry in rodents and humans. Their understanding awaits intensive investigation involving large-population, double-blinded studies.

  • Aurora, R. N., Zak, R. S., Auerbach, S. H., Casey, K. R., Chowduri, S., Krippot, A., Maganti, R. K., Ramar, K., Kristo, D. A., Bista, S. R., Lamm, C. I. & Morgenthaler, T. I. (2010). Standards of practice committee on treatment of nightmares. Journalof Clinical Sleep Medicine, 6, 389401

    • Search Google Scholar
    • Export Citation
  • Blum, K., Chen, A. L., Braverman, E. R., Comings, D. E., Chen, T. J., Arcuri, V., Blum, S. H., Downs, B. W., Waite, R. L., Notaro, A., Lubar, J., Williams, L., Prihoda, T. J., Palomo, T. & Oscar-Berman, M. (2008). Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Journal of Neuropsychiatric Disease and Treatment, 4, 893918

    • Search Google Scholar
    • Export Citation
  • Blum, K., Chen, T. J., Morse, S., Giordano, J., Chen, A. L., Thompson, J., Allen, C., Smolen, A., Lubar, J., Stice, E., Downs, B. W., Waite, R. L., Madigan, M. A., Kerner, M., Fornari, F. & Braverman, E. R. (2010). Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D2 agonist therapy: Part 2. Postgraduate Medical Journal, 122, 214226

    • Search Google Scholar
    • Export Citation
  • Blum, K., Femino, J., Teitlebaum, S., Oscar-Berman, M., Giordano, J. & Gold, M. S. (2013). 12 steps program & fellowship:Neurobiology of recovery. New York: Springer Briefs

    • Search Google Scholar
    • Export Citation
  • Blum, K., Gardner, E., Oscar-Berman, M. & Gold, M. (2012). “Liking” and “wanting” linked to Reward Deficiency Syndrome (RDS): Hypothesizing differential responsivity in brain rewardcircuitry. Current Pharmaceutical Design, 18, 113118

    • Search Google Scholar
    • Export Citation
  • Blum, K., Liu, Y., Wang, W., Wang, Y., Zhang, Y., Oscar-Berman, M., Smolen, A., Febo, M., Han, D., Simpatico, T., Cronjé, F. J., Demetrovics, Z. & Gold, M. S. (2015). rsf MRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts. Postgraduate Medical Journal, 127(2), 232241

    • Search Google Scholar
    • Export Citation
  • Blum, K., Oscar-Berman, M., Femino, J., Waite, R. L., Benya, L., Giordano, J., Borsten, J., Downs, W. B., Braverman, E. R., Loehmann, R., Dushaj, K., Han, D., Simpatico, T., Hauser, M., Barh, D. & McLaughlin, T. J. (2013). Withdrawal from buprenorphine/naloxone and maintenance with a natural dopaminergic agonist: A cautionary note. Journal of Addiction Research and Therapy, 4(2)

    • Search Google Scholar
    • Export Citation
  • Blum, K., Oscar-Berman, M., Stuller, E., Miller, D., Giordano, J., Morse, S., McCormick, L., Downs, W. B., Waite, R. L., Barh, D., Neal, D., Braverman, E. R., Lohmann, R., Borsten, J., Hauser, M., Han, D., Liu, Y., Helman, M. & Simpatico, T. (2012). Neurogenetics and nutrigenomics of neuro-nutrient therapy for Reward Deficiency Syndrome (RDS): Clinical ramifications as a function of molecular neurobiological mechanisms. Journalof Addiction Research and Therapy, 3(5), 139

    • Search Google Scholar
    • Export Citation
  • Febo, M., Blum, K., Liu, Y. & Gold, M. S. (2014). Putative dopamine agonist (KB220Z) enhances resting state functional connectivity in brain reward circuitry. Presentation at Addictions Conference 2014, Aug 4–6, Chicago, USA

    • Search Google Scholar
    • Export Citation
  • Fusar-Poli, P., Perez, J., Broome, M., Borgwardt, S., Placentino, A., Caverzasi, E., Cortesi, M., Veggiotti, P., Politi, P., Barale, F. & McGuire, P. (2007). Neurofunctional correlates of vulnerability to psychosis: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 31, 465484

    • Search Google Scholar
    • Export Citation
  • Gottesmann, C. (2006). The dreaming sleep stage: A new neurobiological model of schizophrenia? Neuroscience, 140, 11051115

  • Gottesmann, C. & Joncas, S. (2000). Letter to the editor: Hypothesis for the neurophysiology of dreaming. Journal of Sleep Reseach, 3, 14

    • Search Google Scholar
    • Export Citation
  • Hinton, D. E., Peou, S., Joshi, S., Nickerson, A. & Simon, N. M. (2013). Normal grief and complicated bereavement among traumatized cambodian refugees: Cultural context and the central role of dreams of the dead. Culture, Medicine, and Psychiatry, 37, 427464

    • Search Google Scholar
    • Export Citation
  • Klinger, E. (1971). Structure and functions of fantasy. 1 st edition (p. 57). New York: Wiley Interscience

  • Kovachy, B., O’Hara, R., Hawkins, N., Gershon, A., Primeau, M. M., Madej, J. & Carrion, V. (2013). Sleep disturbance in pediatric PTSD: Current findings and future directions. Journal of Clinical Sleep Medicne, 9, 501510

    • Search Google Scholar
    • Export Citation
  • McLaughlin, T., Steinberg, B., Christensen, B., Law, I., Parving, A. & Friberg, L. (2014) Potential language and attentional networks revealed through factor analysis of rCBF data measured with SPECT. Journal of Cerebral Blood Flow & Metabolism, 12(4), 535545

    • Search Google Scholar
    • Export Citation
  • Mellman, T. A., David, D., Kulick-Bell, R., Hebding, J. & Nolan, B. (1995). Sleep disturbance and its relationship to psychiatric morbidity after Hurricane Andrew. The American Journal of Psychiatry, 152, 16591663

    • Search Google Scholar
    • Export Citation
  • Nielson, T. & Levin, R. (2007). Nightmares: A new neurocognitive model. Sleep Medicine Reviews, 11, 295310

  • Pearson-Fuhrhop, K. M., Dunn, E. C., Mortero, S., Devan, W. J., Falcone, G. J., Lee, P., Holmes, A. J., Hollinshead, M. O., Roffman, J. L., Smoller, J. W., Rosand, J. & Cramer, S. C. (2014) Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression. PLoS One, 9(5), e93772

    • Search Google Scholar
    • Export Citation
  • Rosen, J., Reynolds, C. F. 3rd, Yeager, A. L., Houck, P. R. & Hurwitz, L. F. (1991). Sleep disturbances in survivors of the Nazi Holocaust. The American Journal of Psychiatry, 148, 6266

    • Search Google Scholar
    • Export Citation
  • Schredl, M., Bohusch, C., Kahl, J., Mader, A. & Somesan, A. (2000). The use of dreams in psychotherapy: A survey of psychotherapists in private practice. The Journal of Psychotherapy Practice and Research, 9, 8187

    • Search Google Scholar
    • Export Citation
  • Sil’kis, I. G. (2006). Role of the basal ganglia in the occurrence of paradoxical sleep dreams (hypothetical mechanism). Zh Vyssh Nerv Deiat Im I P Pavlova, 56, 521

    • Search Google Scholar
    • Export Citation
  • Sil’kis, I. G. (2010.) Paradoxical sleep as a tool for understanding the hippocampal mechanisms of contextual memory. Neuroscienceand Behavioral Physiology, 40, 519

    • Search Google Scholar
    • Export Citation
  • Solms, M. (2000). Dreaming and REM sleep are controlled by different brain mechanisms. Behavioral and Brain Sciences, 23, 843850

  • Spoormaker, V. I., Schredl, M. & van den Bout, J. (2006). Nightmares: from anxiety symptom to sleep disorder. Sleep Medicine Reviews, 10, 1931

    • Search Google Scholar
    • Export Citation
  • Thompson, D. F. & Pierce, D. R. (1999). Drug-induced nightmares. Annals of Pharmacotherapy, 33, 9398

The author instruction is available in PDF.
Please, download the file from HERE

Dr. Zsolt Demetrovics
Institute of Psychology, ELTE Eötvös Loránd University
Address: Izabella u. 46. H-1064 Budapest, Hungary
Phone: +36-1-461-2681
E-mail: jba@ppk.elte.hu

Indexing and Abstracting Services:

  • Web of Science [Science Citation Index Expanded (also known as SciSearch®)
  • Journal Citation Reports/Science Edition
  • Social Sciences Citation Index®
  • Journal Citation Reports/ Social Sciences Edition
  • Current Contents®/Social and Behavioral Sciences
  • EBSCO
  • GoogleScholar
  • PsychInfo
  • PubMed Central
  • SCOPUS
  • Medline
  • CABI
2020  
Total Cites 4024
WoS
Journal
Impact Factor
6,756
Rank by Psychiatry (SSCI) 12/143 (Q1)
Impact Factor Psychiatry 19/156 (Q1)
Impact Factor 6,052
without
Journal Self Cites
5 Year 8,735
Impact Factor
Journal  1,48
Citation Indicator  
Rank by Journal  Psychiatry 24/250 (Q1)
Citation Indicator   
Citable 86
Items
Total 74
Articles
Total 12
Reviews
Scimago 47
H-index
Scimago 2,265
Journal Rank
Scimago Clinical Psychology Q1
Quartile Score Psychiatry and Mental Health Q1
  Medicine (miscellaneous) Q1
Scopus 3593/367=9,8
Scite Score  
Scopus Clinical Psychology 7/283 (Q1)
Scite Score Rank Psychiatry and Mental Health 22/502 (Q1)
Scopus 2,026
SNIP  
Days from  38
sumbission  
to 1st decision  
Days from  37
acceptance  
to publication  
Acceptance 31%
Rate  

2019  
Total Cites
WoS
2 184
Impact Factor 5,143
Impact Factor
without
Journal Self Cites
4,346
5 Year
Impact Factor
5,758
Immediacy
Index
0,587
Citable
Items
75
Total
Articles
67
Total
Reviews
8
Cited
Half-Life
3,3
Citing
Half-Life
6,8
Eigenfactor
Score
0,00597
Article Influence
Score
1,447
% Articles
in
Citable Items
89,33
Normalized
Eigenfactor
0,7294
Average
IF
Percentile
87,923
Scimago
H-index
37
Scimago
Journal Rank
1,767
Scopus
Scite Score
2540/376=6,8
Scopus
Scite Score Rank
Cllinical Psychology 16/275 (Q1)
Medicine (miscellenous) 31/219 (Q1)
Psychiatry and Mental Health 47/506 (Q1)
Scopus
SNIP
1,441
Acceptance
Rate
32%

 

Journal of Behavioral Addictions
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge 850 EUR/article
Printed Color Illustrations 40 EUR (or 10 000 HUF) + VAT / piece
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

Journal of Behavioral Addictions
Language English
Size A4
Year of
Foundation
2011
Publication
Programme
2021 Volume 10
Volumes
per Year
1
Issues
per Year
4
Founder Eötvös Loránd Tudományegyetem
Founder's
Address
H-1053 Budapest, Hungary Egyetem tér 1-3.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-5871 (Print)
ISSN 2063-5303 (Online)

Senior editors

Editor(s)-in-Chief: Zsolt DEMETROVICS

Assistant Editor(s): Csilla ÁGOSTON

Associate Editors

  • Judit BALÁZS (ELTE Eötvös Loránd University, Hungary)
  • Joel BILLIEUX (University of Lausanne, Switzerland)
  • Matthias BRAND (University of Duisburg-Essen, Germany)
  • Anneke GOUDRIAAN (University of Amsterdam, The Netherlands)
  • Daniel KING (Flinders University, Australia)
  • Ludwig KRAUS (IFT Institute for Therapy Research, Germany)
  • H. N. Alexander LOGEMANN (ELTE Eötvös Loránd University, Hungary)
  • Anikó MARÁZ (Humboldt University of Berlin, Germany)
  • Astrid MÜLLER (Hannover Medical School, Germany)
  • Marc N. POTENZA (Yale University, USA)
  • Hans-Jurgen RUMPF (University of Lübeck, Germany)
  • Attila SZABÓ (ELTE Eötvös Loránd University, Hungary)
  • Róbert URBÁN (ELTE Eötvös Loránd University, Hungary)
  • Aviv M. WEINSTEIN (Ariel University, Israel)

Editorial Board

  • Max W. ABBOTT (Auckland University of Technology, New Zealand)
  • Elias N. ABOUJAOUDE (Stanford University School of Medicine, USA)
  • Hojjat ADELI (Ohio State University, USA)
  • Alex BALDACCHINO (University of Dundee, United Kingdom)
  • Alex BLASZCZYNSKI (University of Sidney, Australia)
  • Kenneth BLUM (University of Florida, USA)
  • Henrietta BOWDEN-JONES (Imperial College, United Kingdom)
  • Beáta BÖTHE (University of Montreal, Canada)
  • Wim VAN DEN BRINK (University of Amsterdam, The Netherlands)
  • Gerhard BÜHRINGER (Technische Universität Dresden, Germany)
  • Sam-Wook CHOI (Eulji University, Republic of Korea)
  • Damiaan DENYS (University of Amsterdam, The Netherlands)
  • Jeffrey L. DEREVENSKY (McGill University, Canada)
  • Naomi FINEBERG (University of Hertfordshire, United Kingdom)
  • Marie GRALL-BRONNEC (University Hospital of Nantes, France)
  • Jon E. GRANT (University of Minnesota, USA)
  • Mark GRIFFITHS (Nottingham Trent University, United Kingdom)
  • Heather HAUSENBLAS (Jacksonville University, USA)
  • Tobias HAYER (University of Bremen, Germany)
  • Susumu HIGUCHI (National Hospital Organization Kurihama Medical and Addiction Center, Japan)
  • David HODGINS (University of Calgary, Canada)
  • Eric HOLLANDER (Albert Einstein College of Medicine, USA)
  • Jaeseung JEONG (Korea Advanced Institute of Science and Technology, Republic of Korea)
  • Yasser KHAZAAL (Geneva University Hospital, Switzerland)
  • Orsolya KIRÁLY (Eötvös Loránd University, Hungary)
  • Emmanuel KUNTSCHE (La Trobe University, Australia)
  • Hae Kook LEE (The Catholic University of Korea, Republic of Korea)
  • Michel LEJOXEUX (Paris University, France)
  • Anikó MARÁZ (Eötvös Loránd University, Hungary)
  • Giovanni MARTINOTTI (‘Gabriele d’Annunzio’ University of Chieti-Pescara, Italy)
  • Frederick GERARD MOELLER (University of Texas, USA)
  • Daniel Thor OLASON (University of Iceland, Iceland)
  • Nancy PETRY (University of Connecticut, USA)
  • Bettina PIKÓ (University of Szeged, Hungary)
  • Afarin RAHIMI-MOVAGHAR (Teheran University of Medical Sciences, Iran)
  • József RÁCZ (Hungarian Academy of Sciences, Hungary)
  • Rory C. REID (University of California Los Angeles, USA)
  • Marcantanio M. SPADA (London South Bank University, United Kingdom)
  • Daniel SPRITZER (Study Group on Technological Addictions, Brazil)
  • Dan J. STEIN (University of Cape Town, South Africa)
  • Sherry H. STEWART (Dalhousie University, Canada)
  • Attila SZABÓ (Eötvös Loránd University, Hungary)
  • Ferenc TÚRY (Semmelweis University, Hungary)
  • Alfred UHL (Austrian Federal Health Institute, Austria)
  • Johan VANDERLINDEN (University Psychiatric Center K.U.Leuven, Belgium)
  • Alexander E. VOISKOUNSKY (Moscow State University, Russia)
  • Kimberly YOUNG (Center for Internet Addiction, USA)

 

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 0 23 23
May 2021 0 21 20
Jun 2021 0 26 5
Jul 2021 0 17 10
Aug 2021 0 18 11
Sep 2021 0 8 7
Oct 2021 0 0 0